Skip to content
Disclosery

EXANE DERIVATIVES: FVRR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FVRR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,143 FVRR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,143 shares
    Change vs previous 13F 0 shares

    0.06% of the 13F portfolio, value $108,066.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,143 shares
    Change vs previous 13F +886 shares

    0.07% of the 13F portfolio, value $239,071.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,257 shares
    Change vs previous 13F -1,178 shares

    0.06% of the 13F portfolio, value $256,610.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,435 shares
    Change vs previous 13F +888 shares

    0.16% of the 13F portfolio, value $627,479.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,547 shares
    Change vs previous 13F +1,298 shares

    0.14% of the 13F portfolio, value $588,177.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,249 shares
    Change vs previous 13F -59 shares

    0.08% of the 13F portfolio, value $271,246.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,308 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $255,179.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).